GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stratec SE (XTER:SBS) » Definitions » Institutional Ownership

Stratec SE (XTER:SBS) Institutional Ownership : 36.81% (As of Dec. 13, 2024)


View and export this data going back to 1998. Start your Free Trial

What is Stratec SE Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Stratec SE's institutional ownership is 36.81%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Stratec SE's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Stratec SE's Float Percentage Of Total Shares Outstanding is 0.00%.


Stratec SE Institutional Ownership Historical Data

The historical data trend for Stratec SE's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stratec SE Institutional Ownership Chart

Stratec SE Historical Data

The historical data trend for Stratec SE can be seen below:

2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30
Institutional Ownership 33.94 33.96 33.42 33.75 35.60 36.04 36.16 36.11 36.19 36.81

Stratec SE Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Stratec SE Business Description

Traded in Other Exchanges
Address
Gewerbestrasse 37, Birkenfeld, RP, DEU, 75217
Stratec SE designs and manufactures automated analyzer systems for laboratory data management and solutions for molecular diagnostic sample preparation and stabilization. Its business segments are Instrumentation, Diatron and Smart Consumables. Its Instrumentation segment is engaged in designing and manufacturing automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment comprises the business with systems, system components, consumables, and tests in the low throughput hematology and clinical chemistry segment. Its Smart Consumables segment is engaged in developing and selling scientific materials, such as nucleic acid purification. The company generates maximum revenue from the Instrumentation segment.
Executives
Marcus Wolfinger Board of Directors
Prof. Dr. Georg Heni Supervisory Board